The neuromyelitis optica spectrum disorders: approaches for problem resolution in medical rehabilitation
https://doi.org/10.24884/1607-4181-2016-23-3-11-15
Abstract
The necessity of search of the effective individual programs for rehabilitation in patients with neuromyelitis optica spectrum disorders (NMOSDs) is recognized by majority of authors. Clinical and laboratory features of these patients which could impact on the rehabilitation prognosis were provided in this article. The possible methods for evaluation of the neurological deficit and disability because of NMOSDs were described. The literature data devoted to priority tasks of rehabilitation programs for this category of patients were given.
About the Authors
V. S. Krasnov
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation
V. D. Piven
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
N. A. Totolyan
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
A. A. Gotovchikov
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Переседова Н. А., Черникова Л. А., Завалишин И. А. Физическая реабилитация при рассеянном склерозе: общие принципы и современные высокотехнологичные методы // Актуальные вопросы неврол. и нейрохирургии. – 2013. – № 10. – С. 14–21.
2. Попова Н. А., Матвеева Т. В., Хафизова И. Ф. Оптикомиелит Девика (описание клинического случая) // Практ. мед. – 2004. – № 3 (8). – С. 11–13.
3. Тотолян Н. А., Скоромец А. А. Оптиконейромиелит: учеб. пособие. – СПб.: НИИИЭМ им. Пастера, 2009. – 56 с.
4. Шахов Б. Е., Белова А. Н., Шаленков И. В. и др. Оптикомиелит Девика: вопросы диагностики и описание случая из практики // Мед. альм. – 2012. – № 1. – С. 165–170.
5. Bethoux F., Bennett S. et al. Evaluating Walking in Patients with Multiple Sclerosis: Which Assessment Tools Are Useful in Clinical Practice? // Int. J. of MS Care. – 2011. – № 13 (1). – Р. 4–14.
6. Braley T., Chervin R. et al. Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment // Sleep. – 2010. – № 33 (8). – Р. 1061–1067.
7. Burks J. S., Bigley G. K., Hill H. H. Rehabilitation challenges in multiple sclerosis // Annals of Indian Academy of Neurol. – 2009. – № 12 (4). – Р. 296–306.
8. Cattaneo D., De Nuzzo C., Fascia T. et al. Risks of falls in subjects with multiple sclerosis // Arch. of Phys. Med. and Rehabil. – 2002. – № 83 (6). – Р. 864–867.
9. Cattaneo D., Jonsdottir J., Coote S. Targeting Dynamic Balance in FallsPrevention Interventions in Multiple Sclerosis: Recom mendations from the International MS Falls Prevention Research Network // Int. J. of MS Care. – 2014. – № 16 (4). – Р. 198–202.
10. Hollinger K. R., Franke C. Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder // J. of the Neurol. Sci. – 2016. – № 362. – Р. 85–90.
11. Iida S., Nakamura M., Wate R. et al. Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica // Mult. Scler. Relat Disord. – 2015. – № 4 (5). – Р. 457–459.
12. Kalron A., Nitzani D., Magalashvili D. et al. A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort // BMC Neurology. – 2015. – № 15. – Р. 21.
13. Khan F., Amatya B., Turner5Stokes L. Symptomatic Therapy and Rehabilitation in Primary Progressive Multiple Sclerosis // Neurology Research International. – 2011. – № 2011. – Р. 740–805.
14. Kim S., Go M., Sung J. et al. Painful Tonic Spasm in Neuro myelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics // Arch. Neurol. – 2012. – № 69 (8). – Р. 1026–1031. 15. Kuo5Hsuan C., Long5Sun R., Rong5Kuo L. et al. Biomarkers for neuromyelitis optica // Clinica Chimica Acta. – 2015. – № 440. – Р. 64–71.
15. Lee H. C., Chang K. C., Tsauo J. Y. et al. Effects of a multifactorial fall prevention program on fall incidence and physical function in communitydwelling older adults with risk of falls // N. Arch. Phys. Med. Rehabil. – 2013. – № 94 (4). – Р. 606–615.
16. Lennon V. A., Wingerchuk D. M., Kryzer T. J. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis // Lancet. – 2004. – № 364. – Р. 2106–2112.
17. Lucchinetti C. F., Guo Y., Fujihara K. et al. The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuro myelitis Optica // Br. Pathol. – 2014. – № 24 (1). – Р. 83–97.
18. Massof R. W., Ahmadian L. The Activity Inventory: An Adaptive Visual Function Questionnaire // Optometry & Vision Sci. – 2007. – № 84 (8). – Р. 763–774.
19. Masuda H., Mori M., Uzawa A. et al. Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis // J. of the Neurol. sciences. – 2016. – № 367. – Р. 375–379.
20. Mata S., Lolli F. Neuromyelitis optica: an update // J. Neurol. Sci. – 2011. – № 303 (1–2). – Р. 13–21.
21. Matsuda P. N., Bamer A. M., Johnson S. L. et al. Falls in multiple sclerosis // PMR. – 2011. – № 3 (7). – Р. 624–632.
22. Moore P., Methley A., Pollard C. et al. Cognitive and psychiatric comorbidities in neuromyelitis optica // J. of the Neurol. Sci. – 2016. – № 360. – Р. 4–9.
23. Nechemia Y., Moreh E., Weingarden H. et al. Effectiveness of multidisciplinary rehabilitation for patients with Neuromy elitis Optica // J. Spinal Cord. Med. – № 39 (3). – Р. 311–316.
24. Oh J., Levy M. Neuromyelitis optica: an antibody mediated disorder of the central nervous system // Neurol. Res. Intl. – 2012. – № 2012. – Р. 1–13.
25. Patel F., Elwood D., Kalva S. R. et al. Neuromyelitis Optica in an Inpatient Rehabilitation // Arch. Phys. Med. Rehabil. – 2008. – № 89. – Р. 82.
26. Rabadi M. H., Vincent A. S. Comparison of the Kurtkze Expanded Disability Status Scale and the Functional Indepen dence Measure: measures of multiple sclerosisrelated disability // Disabil. Rehabil. – 2013. – № 35 (22). – Р. 1877–1884.
27. Rahmlow M. R., Boylan K., Freeman W. D. Diaphragmatic pacing to facilitate ventilator weaning in neuromyelitis optica associated respiratory failure // MS Rel. disord. – 2012. – № 1. – Р. 145–147.
28. Sangelaji B., Estebsari F., Nabavi S. M. et al. The effect of exercise therapy on cognitive functions in multiple sclerosis patients: A pilot study // Medical J. of the Islamic Republic of Iran. – 2015. – № 29. – Р. 205.
29. Schreiber A., Fried G., Formal C. Rehabilitation of Neuro myelitis Optica (Devic Syndrome) Three Case Reports // Am. J. Phys. Med. Rehab. – 2008. – № 87 (2). – Р. 144–148.
30. Seok J. M., Cho E. B., Lee H. L. et al. Clinical characteristics of disabling arracks at onset in patients with neuromyelitis optica spectrum disorder // J. of the Neurol. Sci. – 2016. – № 368. – Р. 209–213.
31. Shi Z., Chen H., Lian Z. et al. Factors that impact health related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression // J. Neuroimmunol. – 2016. – № 293. – Р. 54–58.
32. Sorensen J., Lee A., Lovendahl B. et al. Study protocol: to investigate effects of highly specialized rehabilitation for patients with multiple sclerosis. A randomized controlled trial of a personalized, multidisciplinary intervention // BMC Health Services Research. – 2012. – № 12. – Р. 306.
33. Sosnoff J. J., Socie M. J., Boes M. K. et al. Mobility, Balance and Falls in Persons with Multiple Sclerosis // PLoS ONE. – 2011. – № 6 (11). – Р. e28021.
34. Takano R., Misu T., Takahashi T. et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study // Neurol. – 2010. – № 75. – Р. 208–216.
35. Torres J., Pruitt A., Balcer L. Analysis of the treatment of neuromyelitis optica // J. of the Neurol. Sci. – 2015. – № 351. – Р. 31–35.
36. Vitkova M., Rosenberger J., Krokavcova M. et al. Health related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction // Disabil. Rehabil. – 2014. – № 36 12. – Р. 987–992.
37. Wingerchuk D. M., Banwell B., Bennett J. L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders // Neurol. – 2015. – № 85. – Р. 177–189.
38. Wingerchuk D. M., Hogancamp W. F., Weinshenker B. G. et al. The clinical course of neuromyelitis optica (Devic’s syndrome) // Neurology. – 1999. – № 53 (5). – Р. 1107–1114.
39. Wingerchuk D. M., Lennon V. A., Lucchinetti C. F. et al. The spectrum of neuromyelitis optica // Lancet Neurol. – 2007. – № 6. – Р. 805–815.
Supplementary files
|
1. Неозаглавлен | |
| Subject | ||
| Type | Other | |
Download
(212KB)
|
Indexing metadata ▾ | |
Review
For citations:
Krasnov V.S., Piven V.D., Totolyan N.A., Gotovchikov A.A. The neuromyelitis optica spectrum disorders: approaches for problem resolution in medical rehabilitation. The Scientific Notes of the Pavlov University. 2016;23(3):11-15. (In Russ.) https://doi.org/10.24884/1607-4181-2016-23-3-11-15
Views:
1237
Email this article 